Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PDUFA
Biotech
FDA misses PDUFA date for Stealth’s ultra-rare disease candidate
An approval decision for Stealth’s ultra-rare disease candidate has been delayed—again. This time, the FDA hasn't set a new date.
Gabrielle Masson
Apr 30, 2025 9:00am
FDA delays decision on Stealth's ultrarare disease med
Jan 23, 2025 9:45am
FDA delays decision on Moderna's RSV shot until the end of May
May 10, 2024 10:30am
Applied Tx’s pediatric rare disease prosect hits another snag
Mar 29, 2024 10:21am
Karuna's schizophrenia drug set for FDA decision in Q3 2024
Nov 29, 2023 10:00am
FDA delays decision on Valneva's chikungunya vaccine by 3 months
Aug 14, 2023 6:00am